Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Bio Farma Urges OIC Countries to Strengthen Vaccine Cooperation

Published: Monday, June 17, 2013
Last Updated: Monday, June 17, 2013
Bookmark and Share
Bio Farma to make OIC Countries self-reliance in vaccine industry.

Bio Farma has urged Organization of Islamic Cooperation (OIC) member countries to strengthen cooperation in vaccine research to make them self-reliance in vaccine industry.

"We need to strengthen our collaboration in research, production and supply of biological products related to vaccine," Bio Farma President Director Iskandar (one name) said in his presentation in front of vaccine experts attending the 2nd meeting of OIC vaccine & medicine manufacturers, in Bandung, on Sunday.

Prior to Iskandar's presentation on OIC vaccine industry cooperation, delegates from nine OIC member countries (which already have vaccine-making companies or institutions) had approved appointment of Juliman (one name), Bio Farma Director of Production, as chair of the meeting that runs from 16 to 19 June, 2013.

Iskandar emphasized the importance of vaccine research and production among OIC member countries to make them self-reliant in vaccine industry.

He noted the experience of Indonesia, being the world's largest Moslem nation with a population of 240 million, whose need of vaccine has been supplied by the 123-year-old Bio Farma.

For the shorter term period, he said Bio Farma wishes to strengthen the cooperation among Islamic countries in vaccine production while for the medium term it wants to jointly develop new vaccines which are needed by Islamic countries.

Delegates attending the meeting enthusiastically welcomed Indonesia's ideas for an increased cooperation in vaccine research and production to make them self-reliant in vaccine supplies for meeting their needs of vaccine.

Iran and Saudi Arabia, especially, had appreciated Bio Farma's offer for cooperation and initiative on vaccine self-reliance among Islamic countries.

Indonesia's decision to host the meeting is a follow up to the decision of the meeting of Islamic Countries' Advisory Group in Ankara Turkey and the 6th meeting of the OIC Steering Committee on Health in Jakarta.

In addition, the Indonesian government through the letter of the Secretary General of the Ministry of Health to OIC Secretary General has also expressed willingness to host a meeting to finalize the implementation plan for Strategic Health Action Programme 2013-2022.

Bio Farma itself is Indonesia's only vaccine manufacturer whose some of its products have been recognized by the World Health Organization (WHO) so that the company can supply its products to over 100 countries worldwide.

Currently the needs for Expanded Program on Immunization (EPI) vaccines in Indonesia have been supplied solely by Bio Farma by producing and distributing over 1.7 billion doses of vaccine per year to meet the needs of EPI vaccine for national immunization program.

Bio Farma has an outstanding international reputation based on the WHO prequalification for all of its EPI vaccine products. It has also implemented green industry and is environment friendly.

WHO acknowledges that Bio Farma vaccine products are of high quality, efficacious, and affordable.

Bio Farma products are exported to countries around the world through the direct distribution or through various agencies such as UNICEF and PAHO.

The company has obtained the Best Export Performance from the Indonesian Trade Ministry consecutively in 2010, 2011 and 2012 as an evidence of its consistent exceptional performance.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Bio Farma Offers Partnerships in Vaccine Development
Company to partner with vaccine manufacturers in developing and Islamic countries.
Monday, October 29, 2012
Scientific News
First Artificial Ribosome Designed
Researchers at the University of Illinois at Chicago and Northwestern University have engineered a tethered ribosome that works nearly as well as the authentic cellular component, or organelle, that produces all the proteins and enzymes within the cell.
Experimental MERS Vaccine Shows Promise in Animal Studies
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.
Sweet Revenge Against Superbugs
A special type of synthetic sugar could be the latest weapon in the fight against superbugs.
Researchers Develop Vaccine that Protects Primates Against Ebola
A collaborative team from The University of Texas Medical Branch at Galveston and the National Institutes of Health have developed an inhalable vaccine that protects primates against Ebola.
Universal Flu Vaccine in the Works
A new study has demonstrated a potential strategy for developing a flu vaccine with potent, broad protection.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Ferring Bets on Bacteriophages to Treat Inflammatory Bowel Disease
Ferring Pharmaceuticals have annoucned that it will collaborate with Intralytix in the latest phase of its early stage development programme for a bacteriophage-based therapy for inflammatory bowel disease (IBD).
A Novel Drug to FIght Malaria
An international team of scientists has announced that a new compound to fight malaria is ready for human trials.
Ebola Vaccine Trial Begins in Senegal
A clinical trial to evaluate an Ebola vaccine has begun in Dakar, Senegal, after initial research started at the Jenner Institute, Oxford University.
New Cell Structure Finding Might Lead to Novel Cancer Therapies
University of Warwick scientists in the U.K. say they have discovered a cell structure which could help researchers understand why some cancers develop.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!